0001410939-22-000092.txt : 20220804
0001410939-22-000092.hdr.sgml : 20220804
20220804160958
ACCESSION NUMBER: 0001410939-22-000092
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220802
FILED AS OF DATE: 20220804
DATE AS OF CHANGE: 20220804
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Simms Christopher Paul
CENTRAL INDEX KEY: 0001877012
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36080
FILM NUMBER: 221136611
MAIL ADDRESS:
STREET 1: FIVE PENN PLAZA SUITE 2372
CITY: NEW YORK
STATE: NY
ZIP: 10001
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IVERIC bio, Inc.
CENTRAL INDEX KEY: 0001410939
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208185347
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8 SYLVAN WAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
BUSINESS PHONE: (609) 474-6755
MAIL ADDRESS:
STREET 1: 8 SYLVAN WAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
FORMER COMPANY:
FORMER CONFORMED NAME: Ophthotech Corp.
DATE OF NAME CHANGE: 20070828
4
1
wf-form4_165964373903225.xml
FORM 4
X0306
4
2022-08-02
0
0001410939
IVERIC bio, Inc.
ISEE
0001877012
Simms Christopher Paul
C/O IVERIC BIO, INC.
8 SYLVAN WAY
PARSIPPANY
NJ
07054
0
1
0
0
SVP, Chief Commercial Officer
Common Stock
2022-08-02
4
M
0
15000
0
A
22069
D
Common Stock
2022-08-02
4
M
0
18750
0
A
40819
D
Common Stock
2022-08-03
4
S
0
5454
11.25
D
35365
D
Common Stock
2022-08-03
4
S
0
6818
11.25
D
28547
D
Restricted Stock Units
2022-08-02
4
M
0
15000
0
D
Common Stock
15000.0
0
D
Restricted Stock Units
2022-08-02
4
M
0
18750
0
D
Common Stock
18750.0
56250
D
Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units.
Represents shares automatically sold pursuant to the prespecified terms of the applicable Restricted Stock Unit Agreement to satisfy the Reporting Person's minimum statutory withholding obligations with respect to the income recognized by the Reporting Person upon the vesting of the restricted stock units on August 2, 2022.
The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions ranging from $11.14 to $11.38 per share on August 3, 2022 on behalf of a group of employees of the Registrant to satisfy the payment of withholding tax liability of such employees.
Each restricted stock unit represents the contingent right to receive one share of common stock of the Registrant upon vesting of the unit.
Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2019 Inducement Stock Incentive Plan, the award of restricted stock units will vest with respect to 100% of the shares subject to the award on the first anniversary of the grant date.
Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2019 Inducement Stock Incentive Plan, the award of restricted stock units will vest with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date.
/s/ Todd D.C. Anderman, as Attorney-in-Fact for Christopher Simms
2022-08-04